Open Access

Ketamine‑induced bladder dysfunction is associated with extracellular matrix accumulation and impairment of calcium signaling in a mouse model

  • Authors:
    • Cheng‑Huang Shen
    • Shou‑Tsung Wang
    • Shou‑Chieh Wang
    • Shu‑Mei Lin
    • Lei‑Chen Lin
    • Yuan‑Chang Dai
    • Yi‑Wen Liu
  • View Affiliations

  • Published online on: January 29, 2019     https://doi.org/10.3892/mmr.2019.9907
  • Pages: 2716-2728
  • Copyright: © Shen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Due to the rising abuse of ketamine usage in recent years, ketamine‑induced urinary tract syndrome has received increasing attention. The present study aimed to investigate the molecular mechanism underlying ketamine‑associated cystitis in a mouse model. Female C57BL/6 mice were randomly divided into two groups: One group was treated with ketamine (100 mg/kg/day of ketamine for 20 weeks), whereas, the control group was treated with saline solution. In each group, micturition frequency and urine volume were examined to assess urinary voiding functions. Mouse bladders were extracted and samples were examined for pathological and morphological alterations using hematoxylin and eosin staining, Masson's trichrome staining and scanning electron microscopy. A cDNA microarray was conducted to investigate the differentially expressed genes following treatment with ketamine. The results suggested that bladder hyperactivity increased in the mice treated with ketamine. Furthermore, treatment with ketamine resulted in a smooth apical epithelial surface, subepithelial vascular congestion and lymphoplasmacytic aggregation. Microarray analysis identified a number of genes involved in extracellular matrix accumulation, which is associated with connective tissue fibrosis progression, and in calcium signaling regulation, that was associated with urinary bladder smooth muscle contraction. Collectively, the present results suggested that these differentially expressed genes may serve critical roles in ketamine‑induced alterations of micturition patterns and urothelial pathogenesis. Furthermore, the present findings may provide a theoretical basis for the development of effective therapies to treat ketamine‑induced urinary tract syndrome.
View Figures
View References

Related Articles

Journal Cover

April-2019
Volume 19 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Shen CH, Wang ST, Wang SC, Lin SM, Lin LC, Dai YC and Liu YW: Ketamine‑induced bladder dysfunction is associated with extracellular matrix accumulation and impairment of calcium signaling in a mouse model. Mol Med Rep 19: 2716-2728, 2019
APA
Shen, C., Wang, S., Wang, S., Lin, S., Lin, L., Dai, Y., & Liu, Y. (2019). Ketamine‑induced bladder dysfunction is associated with extracellular matrix accumulation and impairment of calcium signaling in a mouse model. Molecular Medicine Reports, 19, 2716-2728. https://doi.org/10.3892/mmr.2019.9907
MLA
Shen, C., Wang, S., Wang, S., Lin, S., Lin, L., Dai, Y., Liu, Y."Ketamine‑induced bladder dysfunction is associated with extracellular matrix accumulation and impairment of calcium signaling in a mouse model". Molecular Medicine Reports 19.4 (2019): 2716-2728.
Chicago
Shen, C., Wang, S., Wang, S., Lin, S., Lin, L., Dai, Y., Liu, Y."Ketamine‑induced bladder dysfunction is associated with extracellular matrix accumulation and impairment of calcium signaling in a mouse model". Molecular Medicine Reports 19, no. 4 (2019): 2716-2728. https://doi.org/10.3892/mmr.2019.9907